Nectero Medical Receives FDA Clearance of IND Application to Initiate Phase II/III Clinical Trial of Nectero EAST® System for Treatment of Small- to Mid-Sized Abdominal Aortic Aneurysms

Nectero Medical has received FDA clearance to begin a Phase II/III clinical trial for their Nectero EAST® System, which aims to treat small- to mid-sized abdominal aortic aneurysms. &nbsp In an exciting development, Nectero Medical, a clinical-stage biotechnology company focused on improving the lives of patients with aneurysmal disease, announced that they have been granted Investigational New ..